Clinical trial
Efficacy and Tolerability of Treatment With Lanthanum Carbonate in Patients With…
NCT00151931 · Shire, Industry · Completed
Key facts
| NCT number | NCT00151931 |
|---|---|
| Title | Efficacy and Tolerability of Treatment With Lanthanum Carbonate in Patients With End Stage Renal Disease Receiving Dialysis |
| Official title | A Multi-Centre, Open-Label Study Assessing the Efficacy and Tolerability of Lanthanum Carbonate in the Reduction of Serum Phosphate Levels in End Stage Renal Disease Patients Receiving Dialysis |
| Lead sponsor | Shire, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Kidney Failure, Chronic |
| Intervention type | Drug |
| Interventions | Lanthanum carbonate |
| Enrollment | 456 |
| Start date | May 11, 2004 |
| Primary completion | Jan 12, 2006 |
| Completion | Jan 12, 2006 |
| First posted | Sep 9, 2005 |
| Last update posted | Jun 8, 2021 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: